Rebecca S Piccolo1, S V Subramanian2, Neil Pearce3, Jose C Florez4, John B McKinlay5. 1. London School of Hygiene and Tropical Medicine, London, U.K. rebecca.piccolo@lshtm.ac.uk. 2. Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA. 3. London School of Hygiene and Tropical Medicine, London, U.K. 4. Diabetes Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, MA. 5. Department of Epidemiology, New England Research Institutes, Watertown, MA.
Abstract
OBJECTIVE: Racial/ethnic minorities in the U.S. have a higher prevalence of type 2 diabetes mellitus (T2DM) than white adults. While many independent risk factors for T2DM have been identified, these determinants are often viewed in isolation without considering the joint contributions of competing risk factors. The objective of this study was to assess the relative contributions of six domains of influence to racial/ethnic disparities in T2DM. RESEARCH DESIGN AND METHODS: Cross-sectional analyses were conducted using the Boston Area Community Health III Survey (2010-2012), the third wave of a population-based sample of men and women from three racial/ethnic groups (black, Hispanic, white) living in Boston, Massachusetts (N = 2,764). Prevalent diabetes was defined by self-report of T2DM, fasting glucose >125 mg/dL, or HbA1c ≥6.5%. Structural equation models were constructed to evaluate the direct effects of each conceptual domain of influence on T2DM prevalence, as well as their indirect effects on the race/ethnicity-T2DM relationship. All direct and indirect pathways were included. RESULTS: The final model indicated that 38.9% and 21.8% of the total effect of black race and Hispanic ethnicity, respectively, on T2DM prevalence was mediated by the socioeconomic, environmental, psychosocial, and lifestyle/behavioral risk scores. The largest mediating influence was the socioeconomic risk score, which explained 21.8% and 26.2% of the total effect of black race and Hispanic ethnicity, respectively. CONCLUSIONS: Our study found that socioeconomic factors had the greatest impact on explaining the excess prevalence of T2DM among racial/ethnic minorities.
OBJECTIVE: Racial/ethnic minorities in the U.S. have a higher prevalence of type 2 diabetes mellitus (T2DM) than white adults. While many independent risk factors for T2DM have been identified, these determinants are often viewed in isolation without considering the joint contributions of competing risk factors. The objective of this study was to assess the relative contributions of six domains of influence to racial/ethnic disparities in T2DM. RESEARCH DESIGN AND METHODS: Cross-sectional analyses were conducted using the Boston Area Community Health III Survey (2010-2012), the third wave of a population-based sample of men and women from three racial/ethnic groups (black, Hispanic, white) living in Boston, Massachusetts (N = 2,764). Prevalent diabetes was defined by self-report of T2DM, fasting glucose >125 mg/dL, or HbA1c ≥6.5%. Structural equation models were constructed to evaluate the direct effects of each conceptual domain of influence on T2DM prevalence, as well as their indirect effects on the race/ethnicity-T2DM relationship. All direct and indirect pathways were included. RESULTS: The final model indicated that 38.9% and 21.8% of the total effect of black race and Hispanic ethnicity, respectively, on T2DM prevalence was mediated by the socioeconomic, environmental, psychosocial, and lifestyle/behavioral risk scores. The largest mediating influence was the socioeconomic risk score, which explained 21.8% and 26.2% of the total effect of black race and Hispanic ethnicity, respectively. CONCLUSIONS: Our study found that socioeconomic factors had the greatest impact on explaining the excess prevalence of T2DM among racial/ethnic minorities.
Authors: A V Diez-Roux; C I Kiefe; D R Jacobs; M Haan; S A Jackson; F J Nieto; C C Paton; R Schulz; A V Roux Journal: Ann Epidemiol Date: 2001-08 Impact factor: 3.797
Authors: Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Julienne K Kirk; Ralph B D'Agostino; Ronny A Bell; Leah V Passmore; Denise E Bonds; Andrew J Karter; K M Venkat Narayan Journal: Diabetes Care Date: 2006-09 Impact factor: 19.112
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: Michael P Bancks; Kiarri Kershaw; April P Carson; Penny Gordon-Larsen; Pamela J Schreiner; Mercedes R Carnethon Journal: JAMA Date: 2017-12-26 Impact factor: 56.272
Authors: Tasneem Khambaty; Neil Schneiderman; Maria M Llabre; Tali Elfassy; Ashley E Moncrieft; Martha Daviglus; Gregory A Talavera; Carmen R Isasi; Linda C Gallo; Samantha A Reina; Denise Vidot; Gerardo Heiss Journal: Int J Behav Med Date: 2020-04
Authors: Hugh C Hendrie; Mengjie Zheng; Kathleen A Lane; Roberta Ambuehl; Christianna Purnell; Shanshan Li; Frederick W Unverzagt; Michael D Murray; Ashok Balasubramanyam; Chris M Callahan; Sujuan Gao Journal: Alzheimers Dement Date: 2018-04-18 Impact factor: 21.566
Authors: Barry W Rovner; Robin J Casten; Catherine Verrier Piersol; Neva White; Megan Kelley; Benjamin E Leiby Journal: J Am Geriatr Soc Date: 2020-02-11 Impact factor: 5.562
Authors: Tesfaye B Mersha; Ke Qin; Andrew F Beck; Lili Ding; Bin Huang; Robert S Kahn Journal: J Allergy Clin Immunol Date: 2021-07-01 Impact factor: 10.793